COVID‐19 pneumonia and pulmonary microembolism in a patient with B‐thalassemia major

We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.

Detalles Bibliográficos
Autores principales: Marziali, Marco, Ribersani, Michela, Losardo, Anna Annunziata, Taglietti, Fabrizio, Pugliese, Pellegrina, Micozzi, Alessandra, Gentile, Giuseppe, Angeloni, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646639/
https://www.ncbi.nlm.nih.gov/pubmed/33173583
http://dx.doi.org/10.1002/ccr3.3275
Descripción
Sumario:We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.

Ejemplares similares